Immunotherapies for COVID-19: lessons learned from sepsis
Kenneth E. Remy(Washington University in St. Louis), Lyle L. Moldawer(University of Florida), Thomas Daix, Robin Jeannet(Hôpital Universitaire Dupuytren), Scott C. Brakenridge(University of Florida), Clifford S. Deutschman(Feinstein Institute for Medical Research), Bruno François(Inserm), Richard S. Hotchkiss(Washington University in St. Louis), Pierre-François Laterre(Cliniques Universitaires Saint-Luc), Guillaume Monneret(Université Claude Bernard Lyon 1)
Cited by 165
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
Sepsis and septic shock
|Nature Reviews Disease Primers|2016|1.6k